about
BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer.Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing.Identification of sentinel lymph nodes by contrast-enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitalsAssociation of GSTP1 methylation with aggressive phenotype in ER-positive breast cancer.Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women.Endocrine sensitivity of estrogen receptor-positive breast cancer is negatively correlated with aspartate-β-hydroxylase expression.Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing.Mutational analysis of AKT1 and PIK3CA in intraductal papillomas of the breast with special reference to cellular components.PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancerIndication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ[Diagnosis of metachronous bilateral breast cancer]Construction of a novel multi-gene assay (42-gene classifier) for prediction of late recurrence in ER-positive breast cancer patientsHighly sensitive detection of sentinel lymph node metastasis of breast cancer by digital PCR for RASSF1A methylationDevelopment of recurrence risk score using 95‑gene classifier and its application to formalin‑fixed paraffin‑embedded tissues in ER‑positive, HER2‑negative and node‑negative breast cancerClinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FECHookwire-guided Sentinel Lymph Node Biopsy Using Contrast-enhanced Ultrasonography Followed by a One-step Nucleic Acid Amplification (OSNA) Assay for Breast CancerDiagnostic Utility of Third-Look, Contrast-Enhanced Sonography Followed by Needle Biopsy for MRI, But Not Second-look Ultrasonography-detected Breast LesionsDrainage of Tumor-Derived DNA into Sentinel Lymph Nodes in Breast Cancer PatientsOne-step Nucleic Acid Amplification Can Identify Sentinel Node-negative Breast Cancer Patients With Excellent PrognosisReal-Time Visualization of Lymphatic Flow to Sentinel Lymph Nodes by Contrast-Enhanced Ultrasonography with Sonazoid in Patients with Breast CancerVasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancerPrognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues
P50
Q35713228-896D9308-4F3A-451D-9AE8-B54060428011Q38913843-594DE670-FBE2-41CA-AC23-B40055EDD23BQ41311451-D0486FCD-0752-4A31-A3CB-ED43A7E05C86Q44184957-38306051-793D-41EE-AB7C-568D59EA37D8Q44908519-651AE620-C3E1-4725-9E1C-E62E580A55BAQ47097891-0134AB69-CB95-4CE7-925E-4FD27F62896CQ48349892-BDE6B067-4377-4685-8F1B-B846AB739D6AQ49896956-0119CE02-373F-40FB-BA05-41F32E33A29EQ58553567-FF86F63D-11BB-4914-BC24-E4E5F6B1E123Q84528615-81DDD7F9-00D9-48BA-A0EC-25656AA9443EQ85957121-DB5E53CE-2B42-4504-B637-FC5147CEF5DCQ88574755-06B72524-2178-48C1-A17A-D5106C318F65Q90868650-4D25D3B0-139F-4F1F-900F-6CD73DD986C9Q90868727-ABA16639-0731-4272-B558-A891D94DB3F8Q90874119-4E13F3FA-2726-4BF5-ADFC-D96FF7FF6947Q91197757-C1CEE449-031B-4C37-8161-C015CEF902D4Q91318718-099A6CC5-80ED-459D-8734-4AE5422E5A0EQ91918182-9CE6B28C-43C6-4A1A-BD63-6667B936AA18Q92176874-6E676D0E-FF0F-43B5-BDD5-6EBAEC8F932EQ92349869-DDAF7CBB-7104-4D68-A5B7-4FCCBF76550CQ92457955-937122A1-CCC3-4106-A03E-30D5EB1FFAAFQ92865736-42B1E5D2-6CAA-4E63-8163-5F3422A68739
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tomohiro Miyake
@ast
Tomohiro Miyake
@de
Tomohiro Miyake
@en
Tomohiro Miyake
@es
Tomohiro Miyake
@fr
Tomohiro Miyake
@it
Tomohiro Miyake
@nl
type
label
Tomohiro Miyake
@ast
Tomohiro Miyake
@de
Tomohiro Miyake
@en
Tomohiro Miyake
@es
Tomohiro Miyake
@fr
Tomohiro Miyake
@it
Tomohiro Miyake
@nl
prefLabel
Tomohiro Miyake
@ast
Tomohiro Miyake
@de
Tomohiro Miyake
@en
Tomohiro Miyake
@es
Tomohiro Miyake
@fr
Tomohiro Miyake
@it
Tomohiro Miyake
@nl
P106
P108
P31
P496
0000-0002-9362-9822